Nature Communications

Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy

2026-05-15

Full text

DOI https://doi.org/10.1038/s41467-026-71710-7